Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 4/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.36 |
| ▸ | FDPS | P14324 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1200445 | 1.00 | ALOX15 (0.63) | ALOX15ALDH1A1USP2TDP1TSHR | |
| SCHEMBL3125002 | 0.94 | ALOX15 (0.61) | ALOX15ALDH1A1USP2TDP1TSHR | |
| SCHEMBL3108399 | 0.94 | ALOX15 (0.61) | ALOX15ALDH1A1USP2TDP1TSHR | |
| SCHEMBL3108390 | 0.94 | ALOX15 (0.61) | ALOX15ALDH1A1USP2TDP1TSHR | |
| SCHEMBL2840564 | 0.92 | ALOX15 (0.59) | ALOX15ALDH1A1USP2TDP1TSHR | |
| SCHEMBL11041920 | 0.92 | ALOX15 (0.59) | ALOX15ALDH1A1USP2TDP1TSHR | |
| SCHEMBL1200044 | 0.86 | ALOX15 (0.68) | ALOX15ALDH1A1USP2TDP1TSHR | |
| SCHEMBL1200047 | 0.86 | ALOX15 (0.68) | ALOX15ALDH1A1USP2TDP1TSHR | |
| SCHEMBL3117924 | 0.86 | ALOX15 (0.68) | ALOX15ALDH1A1USP2TDP1TSHR | |
| SCHEMBL2844694 | 0.85 | ALOX15 (0.61) | ALOX15ALDH1A1USP2TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070352-A | Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof | 切弗朗菲利浦化学公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2026043730-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-26 | — | — | WO | claimed |
| US-20260049256-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2026-02-19 | — | — | US | claimed |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-03 | — | — | US | claimed |
| WO-2025054258-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-03-13 | — | — | WO | claimed |
| US-20250084331-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-03-13 | — | — | US | claimed |
| CN-122070352-A | Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof | 切弗朗菲利浦化学公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12618016-B2 | Methods for producing aviation fuels | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260103649-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2026-04-16 | — | — | US | disclosed |
| WO-2026043730-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-26 | — | — | WO | disclosed |
| US-20260049256-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2026-02-19 | — | — | US | disclosed |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-03 | — | — | US | disclosed |
| US-20250084331-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-03-13 | — | — | US | disclosed |
| US-20040180958-A1 | Method of treatment | PFIZER PRODUCTS INC. | 2004-09-16 | — | — | US | disclosed |
| US-20040157847-A1 | Synergistic combinations | FIELD MARK JOHN (GB) | 2004-08-12 | — | — | US | disclosed |
| WO-2004054560-A1 | ALPHA-2-DELTA LIGAND TO TREAT LOWER URINARY TRACT SYMPTOMS | WARNER-LAMBERT COMPANY LLC (US) | 2004-07-01 | — | — | WO | disclosed |
| US-20040092522-A1 | Synergistic combinations | FIELD MARK JOHN (GB) | 2004-05-13 | — | — | US | disclosed |
| WO-2004016259-A1 | SYNERGISTIC COMBINATION OF AN ALPHA-2-DELTA LIGAND AND A PDEV INHIBITOR FOR USE IN THE TREATMENT OF PAIN | PFIZER LIMITED (GB) | 2004-02-26 | — | — | WO | disclosed |
| US-20030195251-A1 | Amino acids with affinity for the alpha-2-delta-protein | BARTA NANCY SUE (US) | 2003-10-16 | — | — | US | disclosed |
| WO-2003082807-A2 | AMINO ACIDS WITH AFFINITY FOR THE ALPHA-2-DELTA-PROTEIN | WARNER-LAMBERT COMPANY LLC (US) | 2003-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618016-B2 | Methods for producing aviation fuels | CYP4F8, CYP8B1, CYP2E1 | ALOX15 192/4885ALDH1A1 585/4885USP2 1816/4885 |
| US-20250084331-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | ECH1, YAP1, ECHS1 | ALOX15 361/4885ALDH1A1 1172/4885USP2 2908/4885 |
| US-20260103649-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | YAP1, CYP4F8, SCD | ALOX15 871/4885ALDH1A1 1235/4885USP2 3695/4885 |
| US-20040092522-A1 | Synergistic combinations | PDE2A, PDE1B, PDE1A | ALOX15 4732/4885ALDH1A1 1358/4885USP2 2446/4885 |
| US-20040180958-A1 | Method of treatment | BPHL, ADRA2B, ADRB2 | ALOX15 1628/4885ALDH1A1 308/4885USP2 1408/4885 |
| US-20030195251-A1 | Amino acids with affinity for the alpha-2-delta-protein | SCN2A, OPRD1, CAMK2A | ALOX15 4434/4885ALDH1A1 3683/4885USP2 2729/4885 |
| US-20260049256-A1 | METHODS FOR PRODUCING AVIATION FUELS | CYP4F8, CPT1A, CBR1 | ALOX15 245/4885ALDH1A1 902/4885USP2 2692/4885 |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | ADH1A, ADH1C, YAP1 | ALOX15 375/4885ALDH1A1 281/4885USP2 3221/4885 |
| US-20040157847-A1 | Synergistic combinations | PDE2A, PDE1B, PDE1A | ALOX15 4732/4885ALDH1A1 1358/4885USP2 2446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.